According to a recently published paper, fasting 17-gastrin levels well correlate with the diagnosis of overt AIG and type 1 gastric neuroendocrine tumors (35). This evidence concerns the gene GAST and gastric neuroendocrine tumor, well differentiated, low or intermediate grade.